ABSTRACT Furosemide (FURO) is a diuretic and a putative pulmonary vasodilator that, when added to broiler diets, previously has been shown to reduce the cumulative pulmonary hypertension syndrome (PHS) mortality induced by cold temperatures. The objective of the present study was to evaluate the influence of dietary FURO on the pulmonary vasculature in broilers undergoing chronic or acute unilateral pulmonary arterial occlusion. Broilers were fed a standard ration throughout the entire experiment (Control group) or the same ration supplemented with 0.015% (wt/wt) FURO from Day 14 to 42 (FURO group). In the present study chicks were chosen at random at 16 to 18 d of age to undergo sham surgery or a chronic unilateral pulmonary artery clamp ( 
INTRODUCTION
The pathophysiological progression leading to pulmonary hypertension syndrome (PHS, ascites) is characterized by increases in the pulmonary arterial pressure, right:total ventricular weight ratio (RV:TV), cardiac output, and hematocrit and reductions in the saturation of arterial hemoglobin with oxygen (hypoxemia), heart rate, and mean systemic arterial pressure (Julian, 1993; Owen et al., 1995; Wideman and Kirby, 1995; Olkowski et al., 1997; Wideman et al., 1998b; Wideman, 1999, 2000; Wideman, 2000) . The pathogenesis of PHS is initiated when the relatively inelastic pulmonary vasculature of susceptible broilers cannot accommodate, at normal pressures and flow rates, the rapidly increasing cardiac output necessary to support fast growth. Hypoxemia ensues when pulmonary blood flow rates are too high to permit adequate oxygen 937 not differ in body weight or right:total ventricular weight ratios (RV:TV). The postsurgical mortality, ascites mortality, and mortality due to other causes did not differ between the Control-PAC and FURO-PAC groups. Plasma Na + (P ≤ 0.05) was lower in the FURO-Sham group than in the Control-Sham group. Broilers from the same hatch were fed Control or FURO diets and surgically prepared for acute unilateral pulmonary arterial occlusion by using a snare. Tightening of the snare triggered characteristic increases in pulmonary blood flow, pulmonary arterial pressure, and pulmonary vascular resistance. Across all of these variables, the Control and FURO groups did not differ during any sample interval. Dietary FURO did not affect body weight, hematocrit, or RV:TV. Dietary FURO at 0.015% (wt/wt) does not appear to influence the pulmonary vasculature in broilers, but it may prolong the survival of broilers during the pathophysiological progression of PHS.
equilibration, thereby exposing a diffusion limitation. The onset of hypoxemia causes the systemic precapillary arterioles to dilate, thereby reducing the total peripheral resistance and mean systemic arterial pressure in spite of compensatory increments in cardiac output (Peacock et al., 1989 (Peacock et al., , 1990 Wideman and Kirby, 1995; Owen et al., 1995; Wideman, 1999; Wideman, 2000) .
Initial reductions in the systemic arterial pressure trigger a number of mechanisms that activate the renin-angiotensin-aldosterone system and reduce urine flow and osmotically active solute excretion, a phenomenon known as "pressure natriuresis." Further reductions in the systemic arterial pressure reduce the glomerular filtration rate, thereby contributing to large dependent reductions in urine flow and solute excretion (Wideman et al., 1992 Glahn et al., 1993; Forman and Wideman, 1999) . The renal retention of solute and fluid expands the blood volume and contributes to venous congestion, pulmonary arterial hypertension, right-sided congestive heart failure, and ascitic fluid accumulation. A diuretic such as Furosemide (FURO) should alleviate many symptoms of PHS by preventing excessive solute and fluid retention and by increasing venous compliance, which redistributes the blood volume to the venous circulation and reduces the volume of blood that must be propelled through the lungs (Dikshit et al., 1973; Johnston et al., 1983; Silke, 1993; Greenberg et al., 1994) . In mammals, FURO has rapid vasodilator effects attributed to enhanced local endothelial metabolism of prostaglandin F 2α within the kidney (Dikshit et al., 1973; Scherer and Weber, 1979) . The pulmonary metabolism of circulating prostaglandin F 2α metabolites, or the action of circulating FURO to inhibit local endothelial Na
− symport and reduce chloridemediated calcium influx, can elicit pulmonary vasodilation in mammals (Lundergan et al., 1988; Olsen et al., 1992; Greenberg et al., 1994) .
Pulmonary hypertension and the incidence of PHS generally can be reduced by factors that dilate the blood vessels of the lungs and lower the pulmonary vascular resistance, or can be increased by factors that elevate the pulmonary vascular resistance (Owen et al., 1995; Wideman et al., 1995a Wideman et al., ,b, 1996a Wideman, 2000) . Pulmonary vasodilation reduces the pulmonary arterial pressure required to propel blood through the lungs and attenuates hypoxemia associated with a diffusion limitation by slowing the rate of blood flow past the gas exchange surfaces. Consequently, the systemic impact of hypoxemia can also be minimized by permitting the total peripheral resistance and thus mean systemic arterial pressure to increase and the cardiac output to decrease (Wideman et al., 1995b (Wideman et al., , 1996a Wideman and Tackett, 2000; Wideman, 2000) . Furosemide has been evaluated extensively for effectiveness in preventing pulmonary hemorrhage in exercising horses (Goetz and Monohar, 1986; Olsen et al., 1992; Hinchcliff et al., 1996; Rivas and Hinchcliff, 1997) . Feed withdrawal from horses for 3.5 to 5 h before or following FURO injection increased the efficacy of FURO for lowering pulmonary arterial pressures and right atrial pressures when compared with horses provided access to feed and water ad libitum (Olsen et al., 1992; Hinchcliff et al., 1996; Hinchcliff and McKeever, 1998) .
In broilers reared under cold temperature conditions, adding 0.015% (wt/wt) FURO to the diet reduced the cumulative ascites mortality and RV:TV ratios. The longterm survival of male broiler breeders with one chronically occluded pulmonary artery was facilitated by providing one oral 40-mg tablet of FURO coupled with the initiation of feed restriction (Wideman et al., 1995a , Wideman and French, 1999 , 2000 modynamics of broilers fed or treated with FURO had not previously been assessed. The objectives of the present study were to determine whether 0.015% (wt/wt) dietary FURO facilitates pulmonary vasodilation and reduces the incidence of ascites in broilers undergoing chronic or acute unilateral pulmonary arterial occlusion. Unilateral pulmonary arterial occlusion imparts a rigorous challenge to the pulmonary vasculature because the entire cardiac output is forced to flow through only one lung rather than a rise in general blood flow through both lungs, as provoked in broilers reared under cold stress French, 1999, 2000) .
MATERIALS AND METHODS
One hatch of male by-product chicks of the Hubbard 2 6610-HiY breeder pullet line were reared on fresh wood shavings litter in environmental chambers (8 m 2 floor space). They were brooded at 32, 30, and 27 C during Weeks 1, 2, and 3, respectively, and thereafter the temperature was maintained at 24 C. Throughout the experiment, one group of broilers was fed a control diet consisting of a corn-soybean meal-based starter ration formulated to meet NRC (1984) standards for all ingredients, including 22.7% CP, 3,059 kcal/kg ME, 1.5% arginine, 1.43% lysine, and 0.24% sodium. A second group of broilers was fed the control diet until 14 d, then from Days 14 to 42 the same diet was supplemented with 0.015% (wt/wt) FURO 3 (FURO-diet) prior to pelleting. Feed and water in bell waterers were provided for ad libitum consumption.
The protocol for chronic pulmonary artery occlusion was as described previously French, 1999, 2000) . Between Days 16 to 18, broilers were chosen at random from the Control and FURO groups to undergo sham surgery or chronic unilateral pulmonary artery occlusion (PAC), resulting in four experimental groups consisting of Control-Sham (n = 47), FURO-Sham (n = 47), Control-PAC (n = 90), and FURO-PAC (n = 84) broilers. To determine the effect of dietary FURO on the 5-d postsurgical mortality, FURO-Sham and FURO-PAC broilers were fed the FURO diet 3 d prior to undergoing the sham or PAC surgical procedures. Chicks were anesthesized to a surgical plane with an intramuscular injection of a 1:1 mixture of Ketamine 4 HCL (Ketaset, 100 mg/mL) and Xyline (Rompun, 5 100 mg/mL), at 0.007 to 0.015 mL/100 g body mass, and then were fastened to a heated surgical board in a supine position. After a 2% lidocaine 6 infiltration along the skin of the thoracic inlet, a midline incision was made, the crop and trachea were retracted to the right, and the clavicular air sac was opened. At this point, the incision was closed in sham-operated broilers. In the remaining birds, the left pulmonary artery was clamped with a 5-mm silver clip. The incision was closed with surgical staples and swabbed with betadine solution. Broilers were assigned to respective Control-Sham or FURO-Sham groups when an attempt at pulmonary artery occlusion was unsuccessful.
For Control-Sham (n = 32) and FURO-Sham (n = 33) survivors on Day 42, blood samples were collected for measurements of hematocrit, plasma colloid and crystalloid osmotic pressure, 7 and plasma sodium. 8 Necropsies were conducted on all mortalities beginning 5 d postsurgery, as well as on birds surviving to Day 42 of the experiment. The final body weight was recorded, correct placement of the clamp across the pulmonary artery was evaluated, and the heart was removed, dissected, and weighed for calculating the RV:TV, serving as an index of existing pulmonary hypertension (Huchzermeyer et al., 1988) . Broilers dying on Days 16 to 20 were assigned to the 5-d postsurgical mortality category. Broilers dying between Days 21 to 42 and having ascitic fluid were placed in the category for ascites mortality. Broilers dying from other causes between Days 21 to 42 were placed in the other mortality category, regardless of their RV:TV ratio. The survivors on Day 42 without ascitic fluid and having RV:TV ratios ≤0.275 were placed in the clinically healthy category.
The proportions of broiler mortality or survival within each dietary treatment (Control, FURO) and surgical group (Sham, PAC) , and between the three categories (5-d postsurgical, ascites, other) or clinically healthy, were compared by a Z-test with SigmaStat statistical software (Jandel Scientific, 1994) . Differences were considered significant at P ≤ 0.05. Differences in body weight, hematocrit, and plasma variables between sham groups were analyzed by one-way analysis of variance with the Student-Newman-Keuls test for mean separation using SigmaStat statistical software.
Chicks from the same hatch were brooded as described above and were fed the Control (n = 17) or FURO (n = 20) diet. Body weights, hematocrits, and electrocardiograms (ECG; Lead II RS-wave amplitudes in milivolts) were recorded on Day 30. For each ECG recording, three ECG RS-waves were measured to obtain an average R-wave from the baseline to maximum positive peak of the Rwave, and RS-wave from the maximum positive peak of the R-wave to maximum negative value of the S-wave. The S-wave amplitude was calculated from the difference between the RS-and R-wave amplitudes.
The protocol for acute pulmonary artery occlusion has been described previously (Wideman et al. 1996a,b; Forman and Wideman, 1999) . Between 36 and 53 d of age, the largest clinically healthy individuals (Control, n = 9; FURO, n = 10) with bright red combs indicative of normal arterial blood oxygenation were selected to undergo the surgical protocol. The birds were anesthetized to a surgical plane with an intramuscular injection of allobarbital 9 (5,5-diallyl-barbituric acid, 25 mg/kg body weight). They were fastened in dorsal recumbency on a heated surgical board that was thermostatically regulated to maintain a surface temperature of 35 C. One end of the surgical board was elevated to a 20°head-up angle. A 2% lidocane 6 solution was infiltrated intracutaneously as a supplemental local anesthetic along the midline of the thoracic inlet. A midline incision was made, the crop and trachea were retracted laterally, and the clavicular airsac was opened. A snare, consisting of a loop of braided 2-O silk suture thread 10 passed through a 6 cm length of PE290 polyethylene tubing, 11 was placed loosely around the right pulmonary artery. A Transonic 3SB ultrasonic flow probe 12 was positioned on the left pulmonary artery and was filled with acoustical gel. The probe was connected to a Transonic T206 blood flow meter 12 to confirm signal acquisition, and then the skin of the thoracic inlet was sealed with surgical wound clips. The left cutaneous ulnar vein was cannulated with Silastic Laboratory Tubing 11 (0.012 inside diameter × 0.025 outside diameter) filled with 0.9 % sodium chloride containing 200 IU heparin/mL. The distal end of the cannula tubing was attached to a BLPR blood pressure transducer 13 interfaced through a Transbridge preamplifier 13 to a Biopac MP 100 data acquisition system using Acknowledge software.
14 The cannula tubing was advanced slowly through the right atrium and ventricle and was confirmed to be in the left pulmonary artery when advancement of the tip obstructed signal transmission in the flow probe window, after which the cannula was slightly withdrawn until flow probe acquisition resumed. The cannula was confirmed to be in the right pulmonary artery if arterial pulse pressure was lost during transient tightening of the snare, after which the cannula was reinserted into the left pulmonary artery. The left brachial artery and left tibial vein were cannulated with PE50 polyethylene tubing 11 filled with heparinized saline. A solution of 25 g mannitol 9 /L of water was infused i.v. at a constant rate of 0.05 mL/ kg body weight per min to hydrate the birds throughout the experiment.
Following completion of the surgical procedures, a stabilization period of 20 min was allowed to elapse; control data were recorded for 15 min, and the snare was tightened to fully occlude the right pulmonary artery. Data were recorded with the snare tightened for 30 min, after which the snare was released and recovery data were recorded for 15 min. Birds were killed with an i.v. injection of 2 M potassium chloride at the end of the experiment; the heart was removed, dissected, and weighed for calculating the RV:TV ratio.
The Biopac MP 100 data acquisition system recorded pulmonary arterial pressure (mm Hg), blood flow (mm/ min), and cardiac output (mL/min) throughout the experiment. Pulmonary vascular resistance (relative resistance units) was calculated from the ratio of pulmonary arterial pressure divided by cardiac output. The effects of FURO on body weight and heart weights were compared between groups by one-way analysis of variance and the Student-Newman-Keuls test for mean separation using SigmaStat statistical software (Jandel Scientific, 1994). Means within each row having no common superscript differ significantly (P ≤ 0.05).
W-Z
Means within the column for each variable having no common superscript differ significantly (P ≤ 0.05). Control-PAC broilers (n = 100) and FURO-PAC broilers (n = 92) received pulmonary artery clamps on Days 16 to18.
Hemodynamic responses within Control or FURO groups were compared between the presnare control, snare tightening, and recovery periods by repeated measures analysis of variance using SigmaStat statistical software. Differences were considered significant at P ≤ 0.05.
RESULTS and DISCUSSION
Body weights, necropsy categories, and RV:TV ratios of the Control and FURO groups are shown in Table 1 . Ascitic broilers in the PAC groups had lower body weights than the Control-Sham groups, otherwise body weights did not differ between groups in the remaining categories. The percentages of postsurgical and other mortalities did not differ between groups. The percentage of ascites mortality was lower in Sham than in PAC broilers, whereas the percentage of clinically healthy broilers at the time of necropsy was lower in PAC than in Sham broilers. Body weight and the percentages within each necropsy category were not affected by the dietary treatments (Table 1) . Body weights within dietary groups were consistently higher for clinically healthy broilers at necropsy followed by broilers exhibiting pulmonary hypertension at necropsy, ascites mortality, or other mortality groups, respectively. In the PAC groups the percentage of ascites mortality was higher than other categories within sham groups. In the present study, comparisons of the percentage of ascites mortality and RV:TV ratios of the Control-PAC and FURO-PAC groups provide convincing evidence that dietary FURO was incapable of overcoming the volume and pressure overload that chronic unilateral pulmonary arterial occlusion places on the cardiovascular system of full-fed broilers.
Body weights, hematocrit, and plasma values on Days 30, 42, and 36 to 53 for broilers fed the Control or FURO diets are shown in Table 2 . Dietary FURO did not influence body weight in broilers undergoing chronic or acute unilateral pulmonary arterial occlusion or influence hematocrit in broilers on Days 30 and 42. Plasma sodium concentrations were lower (P ≥ 0.05) for broilers fed the FURO diet, whereas plasma colloid osmotic pressure and crystalloid osmolality remained similar between dietary groups on Day 42 (Table 2) . Dietary FURO did not influence lead II electrocardiogram R, RS, and S wave amplitudes on Day 42 or RV:TV ratios between Days 36 to 53 (data not shown). Within the Control and FURO groups, tightening of the pulmonary arterial snare triggered increases in left pulmonary artery blood flow, pulmonary arterial pressure, and pulmonary vascular resistance (Figures 1 to 3) . For all of these variables, no differences were detected between the Control and FURO groups during any of the sample intervals (Figures 1 to 3) . During acute unilateral pulmonary arterial occlusion there was no evidence that dietary FURO was efficacious in lowering the baseline pulmonary vascular resistance or pulmonary arterial pressure, nor did dietary FURO facilitate flow-dependent pulmonary vasodilation during the period of acute unilateral pulmonary arterial occlusion.
Previously, 0.015% (wt/wt) dietary FURO reduced the cumulative ascites mortality and RV:TV ratios in broilers exposed to cold temperatures from Days 21 through 54 (Wideman et al., 1995a) . When broilers are exposed to cold temperatures their metabolic rate increases, and the concurrent rise in cardiac output initiates pulmonary hypertension and exposes a diffusion limitation leading to hypoxemia ; Wideman et al., Means between rows for respective day of age having no common superscript differ significantly (P ≥ 0.05).
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Data are least squares means ± SEM.
2
Sham broilers did not receive pulmonary artery clamps.
3
All broilers were used for acute pulmonary arterial occlusion. 1995a ,b, 1998b Wideman, 2000; Wideman and Tackett, 2000) . Pulmonary hemodynamic characteristics previously were not evaluated in broilers fed FURO (Wideman et al., 1995a) . Additional reports indicate that a large bolus dose of FURO coupled with feed restriction can improve the long-term survival of broilers subjected to chronic unilateral pulmonary artery occlusion French, 1999, 2000) . These observations raised the possibility that, in addition to its diuretic potency, FURO may attenuate the pathogenesis of PHS by acting as a pulmonary vasodilator. In mammalian studies for exam-FIGURE 1. Pulmonary arterial blood flow (mean ± SEM) for broilers in the control (n = 9) or Furosemide (Furo; n = 10) groups at 5-min intervals before tightening the pulmonary artery snare (Samples A to C), at 5-min intervals during unilateral pulmonary artery occlusion for 30 min (Samples Peak to H), and at 5-min intervals after the snare was released (Samples I to J). Different letters designate a significant difference (P ≤ 0.05) within group values within a single sample interval.
ple, FURO is converted to a glucuronide-metabolite by the kidneys and produces a time-dependent (within 15 min) rise in prostaglandin E 2 and prostaglandin F 2α preceding the rise in urine output (Dikshit et al., 1973; Scherer and Weber, 1979) . Furosemide can act indirectly as a pulmonary vasodilator when circulating levels of prostaglandin metabolites, such as endogenous cyclooxygenase products, interact with the lungs to dilate the pulmonary arterioles. In the isolated canine lung, prior treatment with FURO did not appear to potentiate pulmonary vasodilation from residual circulating prostaglandins or the FIGURE 2. Pulmonary arterial blood pressure (mean ± SEM) for broilers in the control (n = 9) and Furosemide (Furo; n = 10) groups at 5-min intervals before tightening the pulmonary artery snare (Samples A to C), at 5-min intervals during unilateral pulmonary artery occlusion for 30 min (Samples Peak to H), and at 5-min intervals after the snare was released (Samples I to J). Different letters designate a significant difference (P ≤ 0.05) within group values within a single sample interval. FIGURE 3. Pulmonary arterial vascular resistance (mean ± SEM) for broilers in the control (n = 9) and Furosemide (FURO) (n = 10) groups at 5-min intervals before tightening the pulmonary artery snare (Samples A to C), at 5-min intervals during unilateral pulmonary artery occlusion for 30 min (Samples Peak to H), and at 5-min intervals after the snare was released (Samples I to J). Different letters designate a significant difference (P ≤ 0.05) within group values within a single sample interval.
possible binding of FURO to prostaglandin sites on plasma proteins (Lundergan et al., 1988) . On the other hand, FURO has been shown to elicit dilation in isolated canine pulmonary and splenic veins and to increase venous capacitance in humans (Johnston et al., 1983; Greenberg et al., 1994) .
Previous studies conducted under very similar experimental conditions revealed an inherent capacity for flowdependent vasodilation in Jungle Fowl fed a typical broiler ration and in broilers fed diets supplemented with 1% arginine (Wideman et al., 1996a (Wideman et al., , 1998a . The present experiments provide no support for the hypothesis that prolonged dietary treatment with 0.015% (wt/wt) FURO contributes to reducing the incidence of ascites by promoting pulmonary vasodilation in broilers.
Furosemide is a carboxylated sulfonamide "loop diuretic" that inhibits Na
− symport in the lumen of the thick ascending limb of Henle's loop in the mammalian-type nephrons of the avian kidney. It is primarily active within the kidney and enters the nephron by organic-acid transport in the proximal tubule and passively by glomerular filtration (Odlind, 1979; Odlind and Dencker, 1981; Osono and Nishimura, 1994) . In mammals the half-life of FURO is approximately 0.3 to 3.4 h with 60% eliminated by the kidney as an intact drug and 40% metabolized by glucuronidation (Jackson, 1996) . It was apparent that the 0.015% (wt/wt) FURO used in both experiments in the present study substantially increased the litter moisture when compared with the litter quality in chambers housing groups fed the Control diet. Coupled with lower plasma Na + levels in the FURO-Sham group than in the Control-Sham group for broilers undergoing chronic unilateral pulmonary arterial oclusion, this evidence indicates the primary efficacy of FURO in the pathogenesis of PHS may be through a reduction in fluid and solute retention by the kidneys.
